Influence of Talc Dose on Extrapleural Talc Dissemination After Talc Pleurodesis
Overview
Affiliations
This study was designed to ascertain, in a rabbit model, extrapleural talc deposition and the related inflammatory response after talc slurry pleurodesis with two clinical doses, 200 and 50 mg/kg. Histopathologic evaluations revealed that whereas numerous rabbits receiving a high dose had talc in the ipsilateral (70%) and contralateral (55%) lung, mediastinum (90%), pericardium (30%), and liver (25%), a small number of animals treated with a low dose showed talc in the ipsilateral lung (10%) and mediastinum (20%) and none in the contralateral lung, pericardium, or liver. Hematologic and immunocytochemical analyses showed that a systemic inflammatory response develops shortly after pleurodesis with a high talc dose involving massive accumulation of neutrophils and macrophages in lung tissue. Zymography also revealed that the pulmonary expression of matrix metalloproteinases 2 and 9 was up-regulated in both lungs in a dose-dependent manner soon after talc instillation. Furthermore, microscopic examination of lung specimens revealed that the higher the dose of talc, the greater the development of both fibrotic visceral pleural thickening and foreign-body granulomas. These findings show pleurodesis with a high talc dose to be associated with an increased risk of extrapleural talc deposition, which may originate undesirable acute and chronic inflammatory responses.
Coca-Perez A, Rivero-Jimenez N, Lopez-Menendez J, Boteanu A, Moreno-Mata N Eur Heart J Case Rep. 2024; 8(12):ytae603.
PMID: 39619724 PMC: 11604065. DOI: 10.1093/ehjcr/ytae603.
Watanabe T, Yamauchi Y, Takeyama R, Kohmaru S, Dejima H, Saito Y Ann Thorac Cardiovasc Surg. 2023; 30(1).
PMID: 37648484 PMC: 10902650. DOI: 10.5761/atcs.oa.23-00115.
Platelet-Rich Plasma for Pleurodesis: An Experimental Study in Rabbits.
Kolokotroni S, Lamprinos D, Goutas N, Kapetanakis E, Kontzoglou K, Perrea D Medicina (Kaunas). 2022; 58(12).
PMID: 36557044 PMC: 9785005. DOI: 10.3390/medicina58121842.
Systemic Inflammatory Response to Different Sclerosing Agents as a Predictor of Pleurodesis Outcome.
Zablockis R, Danila E, Gruslys V, Cincileviciute G In Vivo. 2021; 35(4):2391-2398.
PMID: 34182522 PMC: 8286524. DOI: 10.21873/invivo.12516.
Park E, Kim J, Yee J, Chung J, Seong J, La H Eur J Hosp Pharm. 2019; 26(5):275-279.
PMID: 31656615 PMC: 6788261. DOI: 10.1136/ejhpharm-2017-001465.